Vaxcyte: Sentiment Is Pushing The Shares Down
Source: SeekingAlpha
2025-06-10 13:57:41 ET
Today, I am putting Vaxcyte, Inc. ( PCVX ) in the spotlight for the first time since late 2023. I concluded my last article on this clinical stage vaccine stating the shares looked " fully valued" and declined any investment recommendation around the shares. The stock has dropped approximately 40% since then, prompting a revisit. An updated analysis follows below....
Read the full article on Seeking Alpha
For further details see:
Vaxcyte: Sentiment Is Pushing The Shares Down
Pfizer Inc.
NASDAQ: PFE
PFE Trading
0.24% G/L:
$27.22 Last:
18,921,744 Volume:
$27.20 Open:
PFE Latest News
PFE Stock Data
$156,612,814,520
5,628,850,476
0.02%
1712
N/A
Pharmaceuticals
Healthcare
US
New York
